Mentari Therapeutics

MTRI
18.6001.36% ( +0.250 )
Closed: Nov 13, 16:00:00 (EDT)

Forecast

Forecast & RatingOnly 1 analyst currently covers Mentari Therapeutics (MTRI.US), with a rating of "Buy". The sample is very small, so treat this as a reference only. Data as of Nov 12, 2026; this does not constitute investment advice.

Nov 11, 2026
Price forecast
--100.00%
Forecast & RatingStrong buy
1analysts
  • Strong buy100.00%
  • Buy0.00%
  • Hold0.00%
  • Sell0.00%
  • Strong sell0.00%

Target price forecast

No data available at the moment

Analyst ratings

Strong buy
Buy
Hold
Sell
Strong sell

Source: S&P Global

This information is for reference only and is not investment advice.